ArticleNature communications2026

Harnessing a germ‑free mouse gut bioreactor for directed evolution of probiotics to combat non-alcoholic fatty liver disease.

Zhe Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.